Methods of decreasing amyloid beta (Aβ) plaque deposition and hyperphosphorylated tau plaque deposition in Alzheimer's disease using a cystatin C fusion protein
[US]
○Appl. No. : US16/556,957
○Patent No. : US12115212B2
○Date of Patent : Oct. 15, 2024
